Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Publication of AR122310A1publicationCriticalpatent/AR122310A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Compuestos de la fórmula general (1), o una sal aceptable desde el punto de vista farmacéutico de estos, procesos para la preparación de estos compuestos, composiciones que contienen estos compuestos y los usos de estos compuestos.Compounds of the general formula (1), or a pharmaceutically acceptable salt thereof, processes for the preparation of these compounds, compositions containing these compounds and uses of these compounds.
ARP200102659A2019-09-252020-09-24
STING MODULATORS (STIMULATOR OF INTERFERON GENES)
AR122310A1
(en)
Compounds derived from 2,4-diaminoquinazoline; pharmaceutical composition; and its use for the treatment of a viral infection, cancer, among others (divisional application 202002253).